The Jikei University School of Medicine
Division of Diabetes, Metabolism and Endocrinology
Professor and Chairperson

Mr. Rimei Nishimura

Dr. Rimei Nishimura is a distinguished medical professional who currently serves as Professor and Chairperson of the Division of Diabetes, Metabolism, and Endocrinology at The Jikei University School of Medicine in Tokyo, Japan. He has held various esteemed positions, including Adjunct Assistant Professor at the University of Pittsburgh's Graduate School of Public Health in the United States, contributing significantly to both research and academia.
Since 2006, Dr. Nishimura has played a pivotal role in promoting continuous glucose monitoring (CGM) in Japan and has conducted numerous advanced clinical studies utilizing CGM. His leadership in advancing diabetes treatment in Asia is evident from his invitation to deliver the opening lecture at the inaugural ATTD-ASIA conference held in Singapore in 2024. Dr. Nishimura’s multifaceted career exemplifies his commitment to excellence in research, education, and clinical practice.

Terumo corporation
Development technology department
Director

Mr. Takayuki Sugiyama

To reduce both the physical and psychological burden for patients requiring insulin therapy and to support treatment continuity, this lecture will explain the development of devices designed for that purpose. As concrete examples, we will focus on the world’s thinnest tapered needle and Japan’s first patch-type insulin pump, explaining the challenges encountered during development and in clinical practice, as well as future prospects.

Light Touch Technology Inc.

Dr. Koichi Yamakawa

Diabetes patients measure their blood glucose levels multiple times a day using devices such as self-monitoring of blood glucose (SMBG) meters. SMBG requires measuring blood obtained by pricking a finger with a needle, presenting patients with numerous issues including inconvenience, pain, psychological stress, and the risk of infection. Furthermore, hospitals where daily blood glucose monitoring is performed, there is significant expectation for non-invasive measurement that eliminates blood sampling.
By integrating cutting-edge laser technology, we have successfully developed a mid-infrared laser with brightness orders of magnitude higher than conventional light sources, establishing a new non-invasive blood glucose measurement technology.
This presentation reports on the current status of development toward commercializing a compact non-invasive blood glucose sensor suitable for widespread use from households to hospitals, and explores new possibilities for diabetes care.